Company intelligence / Profile preview

PenRad Technologies

Buffalo, Minnesota, United States

Ownership: Private
Employees: ~39
Development stage: Other

Overview

PenRad Technologies was a software provider for medical imaging informatics, specializing in breast imaging and lung cancer screening. Its core products included PenRad (breast imaging informatics), PenLung (lung screening), PenTrac (patient tracking), and PenAlert (patient-friendly reporting). Founded in 1995, it was acquired by Intelerad Medical Systems on August 16, 2022.

Therapeutic areas: Oncology
Industry: Medical Imaging

Partnerships

NovaradCoActiv MedicalCarestream HealthVolparaSalient ImagingDilon Diagnostics

Beyond the preview

Go deeper on PenRad Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PenRad Technologies.

Explore the full profile